INS and metabolic syndrome: The elevated lysoPC(15:0) content was causally related to the risk of high uric acid, high insulin, high homeostasis model assessment of insulin resistance (HOMA-IR), dyslipidemia, and overweight/obesity, which shows that abnormal lysoPC metabolism may be connected to the metabolic risk [33,40].